- Home
- OMH vs QNTM Comparison
OMH vs QNTM Comparison
Compare OMH & QNTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMH
- QNTM
- Stock Information
- Founded
- OMH 2015
- QNTM 1998
- Country
- OMH Singapore
- QNTM Canada
- Employees
- OMH N/A
- QNTM N/A
- Industry
- OMH Real Estate
- QNTM
- Sector
- OMH Finance
- QNTM
- Exchange
- OMH Nasdaq
- QNTM NYSE
- Market Cap
- OMH 8.4M
- QNTM 9.1M
- IPO Year
- OMH 2023
- QNTM N/A
- Fundamental
- Price
- OMH $0.35
- QNTM $6.23
- Analyst Decision
- OMH Strong Buy
- QNTM
- Analyst Count
- OMH 1
- QNTM 0
- Target Price
- OMH $1.50
- QNTM N/A
- AVG Volume (30 Days)
- OMH 143.0K
- QNTM 7.0M
- Earning Date
- OMH 09-25-2024
- QNTM 03-31-2025
- Dividend Yield
- OMH N/A
- QNTM N/A
- EPS Growth
- OMH N/A
- QNTM N/A
- EPS
- OMH N/A
- QNTM N/A
- Revenue
- OMH $5,390,607.00
- QNTM N/A
- Revenue This Year
- OMH $101.90
- QNTM N/A
- Revenue Next Year
- OMH $38.34
- QNTM N/A
- P/E Ratio
- OMH N/A
- QNTM N/A
- Revenue Growth
- OMH 25.77
- QNTM N/A
- 52 Week Low
- OMH $0.32
- QNTM $2.70
- 52 Week High
- OMH $1.15
- QNTM $70.20
- Technical
- Relative Strength Index (RSI)
- OMH 46.75
- QNTM 46.46
- Support Level
- OMH $0.34
- QNTM $10.68
- Resistance Level
- OMH $0.38
- QNTM $12.44
- Average True Range (ATR)
- OMH 0.03
- QNTM 2.41
- MACD
- OMH 0.00
- QNTM -0.42
- Stochastic Oscillator
- OMH 19.05
- QNTM 21.66
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, Property Management Services, and revenue from emerging and other services.
About QNTM QUANTUM BIOPHARMA LTD
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.